Compound Summary
Compound Name: | 			GR 46611 | 
Compound CID: | 			6160690 | 
Synonyms: | 			GR 46611 185259-85-2 3-3-(2-Dimethylaminoethyl)-1H-indol-5-yl-N-(4-methoxybenzyl)acrylamide GR46611 GR 4661 More... | 
Iupac Name: | 			(E)-3-[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-N-[(4-methoxyphenyl)methyl]prop-2-enamide | 
InChI: | 					InChI=1S/C23H27N3O2/c1-26(2)13-12-19-16-24-22-10-6-17(14-21(19)22)7-11-23(27)25-15-18-4-8-20(28-3)9-5-18/h4-11,14,16,24H,12-13,15H2,1-3H3,(H,25,27)/b11-7+ | 
InChIKey: | 				LBVZWEWTNUDWNS-YRNVUSSQSA-N | 
Canonical Smiles: | 		CN(C)CCC1=CNC2=C1C=C(C=C2)C=CC(=O)NCC3=CC=C(C=C3)OC | 
Isomeric Smiles: | 			CN(C)CCC1=CNC2=C1C=C(C=C2)/C=C/C(=O)NCC3=CC=C(C=C3)OC | 
Molecular Weight: | 		377.5 | 
Molecular Formula: | 			C23H27N3O2 | 
Molecular Weight: | 		377.5 | 
Molecular Formula: | 			C23H27N3O2 | 
Hydrogen Bond Donor Count: | 			2 | 
Hydrogen Bond Acceptor Count: | 			3 | 
Rotatable Bond Count: | 			8 | 
Heavy Atom Count: | 					28 | 
Complexity: | 				514 | 
| GR 46611 | GR 46611 | 
|---|---|
GR 46611 | 			
185259-85-2 | 
3-3-(2-Dimethylaminoethyl)-1H-indol-5-yl-N-(4-methoxybenzyl)acrylamide | 			
GR46611 | 
GR 4661 | 			
CHEMBL344127 | 
(E)-3-3-2-(dimethylamino)ethyl-1H-indol-5-yl-N-(4-methoxyphenyl)methylprop-2-enamide | 			
SR-01000076206 | 
3-(3-(2-Dimethylaminoethyl)-1H-indol-5-yl)-N-(4-methoxybenzyl)acrylamide | 			
Lopac0_000069 | 
MLS001056583 | 			
SCHEMBL4784832 | 
CHEBI:93195 | 			
(E)-3-(3-(2-(dimethylamino)ethyl)-1H-indol-5-yl)-N-(4-methoxybenzyl)acrylamide | 
HMS2233M08 | 			
HMS3260M19 | 
HMS3411P15 | 			
HMS3675P15 | 
ZINC840177 | 			
Tox21_500069 | 
BDBM50054764 | 			
PDSP1_001395 | 
PDSP2_001379 | 			
AKOS024458670 | 
CCG-204164 | 			
GR-4661 | 
LP00069 | 			
SDCCGSBI-0050057.P002 | 
NCGC00024831-02 | 			
NCGC00024831-03 | 
NCGC00024831-04 | 			
NCGC00024831-05 | 
NCGC00260754-01 | 			
SMR000326973 | 
EU-0100069 | 			
G 8543 | 
SR-01000076206-1 | 			
SR-01000076206-3 | 
2-METHYL-5-(PIPERIDINOSULFONYL)-3-FUROICACID | 			
BRD-K68190965-001-01-4 | 
3-3-(2-dimethylaminoethyl)-1h-indol-5-yl-n-(4-methoxybenzyl) acrylamide | 			
(E)-3-3-(2-Dimethylamino-ethyl)-1H-indol-5-yl-N-(4-methoxy-benzyl)-acrylamide | 
2-Propenamide, 3-(3-(2-(dimethylamino)ethyl)-1H-indol-5-yl)-N-((4-methoxyphenyl)methyl)- | 			
3-(3-(2-(dimethylamino)ethyl)-1h-indol-5-yl)-n-(4-methoxybenzyl)acrylamide | 
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab | 
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33.000000000000000 | umol/L | -5.000000000000000 | NS | N2 | 24134630 | Inactive | 
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point | 
|---|---|---|---|---|
| Caenorhabditis elegans | -5.000000000000000 | 1 | 1 |